A defect in thromboxane a2 synthesis may be a factor predisposing to cancer
- 31 August 1978
- journal article
- Published by Elsevier in Prostaglandins and Medicine
- Vol. 1 (2) , 175-181
- https://doi.org/10.1016/0161-4630(78)90045-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Thromboxane A2: A key regulator of prostaglandin biosynthesis and of interactions between prostaglandins, calcium and cyclic nucleotidesMedical Hypotheses, 1978
- Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or plateletsEuropean Journal of Pharmacology, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- Prostaglandins and cancerCancer Treatment Reviews, 1976
- Prostaglandins and cancer: An updateProstaglandins, 1974
- CANCER CACHEXIA AND GLUCONEOGENESISAnnals of the New York Academy of Sciences, 1974
- Stimulation of glycolysis by imidazoleLife Sciences, 1973
- A Unifying Concept of Carcinogenesis and its Therapeutic ImplicationsOncology, 1973
- Biologically active prostaglandins from some new odd‐numbered essential fatty acidsRecueil des Travaux Chimiques des Pays-Bas, 1968
- The Role of Glycolysis in the Growth of Tumor CellsPublished by Elsevier ,1961